Primary Job Title Member of the Board of Advisors Primary Organization 
Medicxi
Location Almere, Flevoland, The Netherlands Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
Mark was formerly with Index Ventures, which he joined in 2005 as a Venture Partner. He has been involved in many investments, including Comentis, Molecular Partners (SWX:MOLN), PanGenetics (acquired by Abbott), ProFibrix (acquired by The Medicines Company) and Versartis (Nasdaq: VSAR).
He is an advisor to the Utrecht University Technology
Transfer Office and Holdings. He has worked for, managed and founded a number of early-stage biopharmaceutical companies in the field of innovative novel biopharmaceuticals.Mark graduated in Biochemistry and has a PhD from the University of Amsterdam.
